|
|
|
Volumn 47, Issue 1, 2012, Pages 26-38
|
|
Almost half of new molecular entities approved in 2011 considered significant therapeutic advances
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABIRATERONE ACETATE;
ANASCORP;
APIXABAN;
ARIPIPRAZOLE;
ASPARAGINASE;
AZFICEL T;
AZILSARTAN MEDOXOMIL;
BELATACEPT;
BELIMUMAB;
BOCEPREVIR;
BRENTUXIMAB VEDOTIN;
CLOBAZAM;
CLOPIDOGREL;
COMPLEMENT COMPONENT C1S INHIBITOR;
CORIFACT;
CORTICOSTEROID;
CRIZOTINIB;
DABIGATRAN;
DABIGATRAN ETEXILATE;
DACARBAZINE;
DEFERIPRONE;
DOCETAXEL;
ECALLANTIDE;
EYLEA;
FIDAXOMICIN;
GABAPENTIN ENACARBIL;
GADOBUTROL;
GLUCOCORTICOID;
GLYCOPROTEIN GP 100;
HEMACORD;
HYDROXYUREA;
ICATIBANT;
INDACATEROL;
IOFLUPANE I 123;
IPILIMUMAB;
KEDBUMIN;
LINAGLIPTIN;
NONSTEROID ANTIINFLAMMATORY AGENT;
ORPHAN DRUG;
PEGINTERFERON;
PEGINTERFERON ALPHA2A;
PREDNISONE;
QUETIAPINE;
RANIBIZUMAB;
RETIGABINE;
RIBAVIRIN;
RILPIVIRINE;
RIVAROXABAN;
ROFLUMILAST;
RUXOLITINIB;
SPHERUSOL;
SPINOSAD;
TELAPREVIR;
TICAGRELOR;
TUMOR VACCINE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VANDETANIB;
VEMURAFENIB;
VILAZODONE;
WARFARIN;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ANGIONEUROTIC EDEMA;
ANTICOAGULATION;
ANTINEOPLASTIC ACTIVITY;
AUTOIMMUNE DISEASE;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
BLEEDING;
CANCER THERAPY;
CASTRATION RESISTANT PROSTATE CANCER;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
DEPRESSION;
DIABETES MELLITUS;
DIARRHEA;
DIZZINESS;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG MECHANISM;
DRUG POTENCY;
DRUG SAFETY;
DRUG SCREENING;
EDEMA;
EUROPEAN UNION;
FATIGUE;
FOOD AND DRUG ADMINISTRATION;
GENETIC SCREENING;
HEADACHE;
HEART ATRIUM FIBRILLATION;
HEPATITIS C;
HODGKIN DISEASE;
HOT FLUSH;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERTENSION;
INFECTIOUS DIARRHEA;
IRON OVERLOAD;
KIDNEY GRAFT REJECTION;
LARGE CELL LYMPHOMA;
LUNG NON SMALL CELL CANCER;
MELANOMA;
MUTATIONAL ANALYSIS;
MYELOFIBROSIS;
NAUSEA;
NERVE INJURY;
NEUTROPENIA;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PEDICULOSIS CAPITIS;
PNEUMONIA;
RASH;
RESTLESS LEGS SYNDROME;
REVIEW;
SEIZURE;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
STROKE;
SURVIVAL RATE;
SWELLING;
SYSTEMIC LUPUS ERYTHEMATOSUS;
THROMBOCYTOPENIA;
THYROID MEDULLARY CARCINOMA;
UNITED STATES;
VISUAL DISORDER;
VOMITING;
|
|
EID: 84856832760
PISSN: 1082801X
EISSN: 19381166
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (0)
|
